Cadila Healthcare gains despite reporting 17% fall in Q2 consolidated net profit

05 Nov 2018 Evaluate

Cadila Healthcare is currently trading at Rs. 361.20, up by 1.90 points or 0.53% from its previous closing of Rs. 359.30 on the BSE.

The scrip opened at Rs. 351.00 and has touched a high and low of Rs. 363.20 and Rs. 348.00 respectively. So far 74801 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 510.85 on 07-Nov-2017 and a 52 week low of Rs. 330.65 on 26-Oct-2018.

Last one week high and low of the scrip stood at Rs. 365.75 and Rs. 340.00 respectively. The current market cap of the company is Rs. 36946.87 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.34% and 7.87% respectively.

Cadila Healthcare has reported a rise of 48.18% in its net profit at Rs 666.50 crore for the quarter ended September 30, 2018 as compared to Rs 449.80 crore for the same quarter in the previous year. Total income of the company increased by 13.77% at Rs 2,054.30 crore for Q2FY19 as compared Rs 1,805.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 17.05% in its net profit at Rs 417.50 crore for the quarter under review as compared to Rs 503.30 crore for the same quarter in the previous year. Total income of the company decreased by 7.79% at Rs 2,991.60 crore for Q2FY19 as compared Rs 3,244.40 crore for the corresponding quarter previous year.

Zydus Lifesciences Share Price

890.10 -3.35 (-0.37%)
28-Jan-2026 09:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1632.50
Dr. Reddys Lab 1232.00
Cipla 1314.45
Zydus Lifesciences 890.10
Lupin 2140.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×